These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 20017672

  • 1. TaqMan low-density arrays and analysis by artificial neuronal networks predict response to neoadjuvant chemoradiation in esophageal cancer.
    Warnecke-Eberz U, Metzger R, Bollschweiler E, Baldus SE, Mueller RP, Dienes HP, Hoelscher AH, Schneider PM.
    Pharmacogenomics; 2010 Jan; 11(1):55-64. PubMed ID: 20017672
    [Abstract] [Full Text] [Related]

  • 2. High cyclooxygenase-2 expression following neoadjuvant radiochemotherapy is associated with minor histopathologic response and poor prognosis in esophageal cancer.
    Xi H, Baldus SE, Warnecke-Eberz U, Brabender J, Neiss S, Metzger R, Ling FC, Dienes HP, Bollschweiler E, Moenig S, Mueller RP, Hoelscher AH, Schneider PM.
    Clin Cancer Res; 2005 Dec 01; 11(23):8341-7. PubMed ID: 16322294
    [Abstract] [Full Text] [Related]

  • 3. Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancer.
    Schneider S, Uchida K, Brabender J, Baldus SE, Yochim J, Danenberg KD, Salonga D, Chen P, Tsao-Wei D, Groshen S, Hoelscher AH, Schneider PM, Danenberg PV.
    J Am Coll Surg; 2005 Mar 01; 200(3):336-44. PubMed ID: 15737843
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of survivin mRNA is associated with a favorable prognosis following neoadjuvant radiochemotherapy in esophageal cancer.
    Warnecke-Eberz U, Hokita S, Xi H, Higashi H, Baldus SE, Metzger R, Brabender J, Bollschweiler E, Mueller RP, Dienes HP, Hoelscher AH, Schneider PM.
    Oncol Rep; 2005 Jun 01; 13(6):1241-6. PubMed ID: 15870949
    [Abstract] [Full Text] [Related]

  • 5. Failure in downregulation of intratumoral survivin expression following neoadjuvant chemoradiation in esophageal cancer.
    Vallböhmer D, Kuhn E, Warnecke-Eberz U, Brabender J, Hoffmann AC, Metzger R, Baldus SE, Drebber U, Hoelscher AH, Schneider PM.
    Pharmacogenomics; 2008 Jun 01; 9(6):681-90. PubMed ID: 18518847
    [Abstract] [Full Text] [Related]

  • 6. Quantitative analysis of survivin RNA expression in blood as a non-invasive predictor of response to neoadjuvant radiochemotherapy in esophageal cancer.
    Grimminger P, Vallböhmer D, Hoffmann A, Schulte C, Bollschweiler E, Schneider PM, Hölscher AH, Metzger R, Brabender J.
    J Surg Oncol; 2009 Nov 01; 100(6):447-51. PubMed ID: 19653263
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Death-associated protein kinase (DAPK) promoter methylation and response to neoadjuvant radiochemotherapy in esophageal cancer.
    Brabender J, Arbab D, Huan X, Vallböhmer D, Grimminger P, Ling F, Neiss S, Bollschweiler E, Schneider PM, Hölscher AH, Metzger R.
    Ann Surg Oncol; 2009 May 01; 16(5):1378-83. PubMed ID: 19224282
    [Abstract] [Full Text] [Related]

  • 9. High specificity of quantitative excision repair cross-complementing 1 messenger RNA expression for prediction of minor histopathological response to neoadjuvant radiochemotherapy in esophageal cancer.
    Warnecke-Eberz U, Metzger R, Miyazono F, Baldus SE, Neiss S, Brabender J, Schaefer H, Doerfler W, Bollschweiler E, Dienes HP, Mueller RP, Danenberg PV, Hoelscher AH, Schneider PM.
    Clin Cancer Res; 2004 Jun 01; 10(11):3794-9. PubMed ID: 15173087
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Response evaluation by endoscopy, rebiopsy, and endoscopic ultrasound does not accurately predict histopathologic regression after neoadjuvant chemoradiation for esophageal cancer.
    Schneider PM, Metzger R, Schaefer H, Baumgarten F, Vallbohmer D, Brabender J, Wolfgarten E, Bollschweiler E, Baldus SE, Dienes HP, Hoelscher AH.
    Ann Surg; 2008 Dec 01; 248(6):902-8. PubMed ID: 19092334
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. MicroRNA profiling in locally advanced esophageal cancer indicates a high potential of miR-192 in prediction of multimodality therapy response.
    Odenthal M, Bollschweiler E, Grimminger PP, Schröder W, Brabender J, Drebber U, Hölscher AH, Metzger R, Vallböhmer D.
    Int J Cancer; 2013 Nov 15; 133(10):2454-63. PubMed ID: 23649428
    [Abstract] [Full Text] [Related]

  • 15. Roles of thymidylate synthase and dihydropyrimidine dehydrogenase expression in blood as predictors of response to multimodal therapy in esophageal cancer.
    Brabender J, Metzger R, Vallböhmer D, Ling F, Neiss S, Bollschweiler E, Schneider PM, Hölscher AH, Grimminger PP.
    Surgery; 2012 Feb 15; 151(2):306-12. PubMed ID: 21982526
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Gene expression profiles of epidermal growth factor receptor, vascular endothelial growth factor and hypoxia-inducible factor-1 with special reference to local responsiveness to neoadjuvant chemoradiotherapy and disease recurrence after rectal cancer surgery.
    Toiyama Y, Inoue Y, Saigusa S, Okugawa Y, Yokoe T, Tanaka K, Miki C, Kusunoki M.
    Clin Oncol (R Coll Radiol); 2010 May 15; 22(4):272-80. PubMed ID: 20117921
    [Abstract] [Full Text] [Related]

  • 19. [Preoperative chemoradiation in esophageal cancer: experience of a single center in 102 patients].
    Imdahl A, Schöffel U, Ruf G, Hopf UT.
    Zentralbl Chir; 2004 Oct 15; 129(5):350-5. PubMed ID: 15486784
    [Abstract] [Full Text] [Related]

  • 20. DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapy.
    Ott K, Rachakonda PS, Panzram B, Keller G, Lordick F, Becker K, Langer R, Buechler M, Hemminki K, Kumar R.
    Ann Surg Oncol; 2011 Sep 15; 18(9):2688-98. PubMed ID: 21347786
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.